A stack by mendtherapy
Tendon and soft-tissue repair
The most commonly described recovery pairing. BPC-157 runs throughout; TB-500 front-loads and then stops, which is the part most write-ups leave out.
mendtherapy wrote this as a plan rather than a record. There is no dose log behind it, and nothing here says anybody followed it.
The schedule
| Compound | Dose | How often | Weeks |
|---|---|---|---|
| BPC-157Often split into two smaller doses. The site's profile gives 250 to 500 mcg once or twice daily. | 500 mcg | Once daily | 1–6 |
| TB-500The loading phase. Descriptions of this compound almost always taper after four to six weeks rather than continuing. | 2.5 mg | Weekly · Mon, Thu | 1–4 |
Read thisThis is one person’s plan, published by them. We did not write it, check it, or verify that they followed it — and one person doing something is not evidence that it works or that it is safe. Every compound above links to what the published research actually says.
Report this
This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on Bioalmanac is medical advice.
2 comments
Written by readers, not by us. Nothing here is checked, and a confident reply is not evidence.
3 Sept 2026
The TB-500 stopping at week four is the part almost every version of this leaves out. Worth saying why: the compound page here notes the loading phase is what the animal work used, and continuing past it is somebody's extrapolation rather than a finding.
3 Sept 2026
Worth checking the arithmetic before mixing: 2.5 mg twice weekly from a 10 mg vial is four doses, so a vial lasts two weeks at this schedule. The calculator on this site will draw it on the barrel if you put the vial size in.
Create an account to comment. Reading takes none.